# Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis

> **NCT02390726** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Vermont** · enrollment: 20 (estimated)

## Conditions studied

- Ulcerative Colitis, Active Moderate

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplant
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02390726
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390726, "Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02390726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*